Rezpegaldesleukin (LY3471851), a PEGylated recombinant IL‐2, was confirmed in non‐central nervous system (CNS)‐ or non‐kidney‐involved active SLE patients at NCT04433585 [263]. This evidence concerns the gene IL2 and systemic lupus erythematosus.